SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-19-000202
Filing Date
2019-09-06
Accepted
2019-09-06 17:01:43
Documents
63
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 1081534
2 EXHIBIT 10.1 exhibit10_1.htm EX-10.1 396797
3 EXHIBIT 10.2 exhibit10_2.htm EX-10.2 16678
4 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 14794
5 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 14139
6 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 7929
7 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 8399
  Complete submission text file 0001513162-19-000202.txt   5341202

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT anix-20190731.xml EX-101.INS 1122079
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20190731.xsd EX-101.SCH 48979
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anix-20190731_cal.xml EX-101.CAL 28415
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anix-20190731_def.xml EX-101.DEF 255025
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anix-20190731_lab.xml EX-101.LAB 320392
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20190731_pre.xml EX-101.PRE 246876
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-37492 | Film No.: 191080218
SIC: 8071 Services-Medical Laboratories
Assistant Director 9